ATE202633T1 - Kalibrator für prothrombin-zeit-assays - Google Patents

Kalibrator für prothrombin-zeit-assays

Info

Publication number
ATE202633T1
ATE202633T1 AT95917181T AT95917181T ATE202633T1 AT E202633 T1 ATE202633 T1 AT E202633T1 AT 95917181 T AT95917181 T AT 95917181T AT 95917181 T AT95917181 T AT 95917181T AT E202633 T1 ATE202633 T1 AT E202633T1
Authority
AT
Austria
Prior art keywords
calibrator
prothrombin time
time assay
assay
recombinant
Prior art date
Application number
AT95917181T
Other languages
English (en)
Inventor
Barry J Woodhams
Michael E Burgess-Wilson
Original Assignee
Dade Behring Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Inc filed Critical Dade Behring Inc
Application granted granted Critical
Publication of ATE202633T1 publication Critical patent/ATE202633T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96447—Factor VII (3.4.21.21)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664—Blood serum or blood plasma standard or control

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
AT95917181T 1994-04-28 1995-04-28 Kalibrator für prothrombin-zeit-assays ATE202633T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23501694A 1994-04-28 1994-04-28
PCT/US1995/005195 WO1995030154A1 (en) 1994-04-28 1995-04-28 Calibrator for prothrombin time (pt) assays

Publications (1)

Publication Number Publication Date
ATE202633T1 true ATE202633T1 (de) 2001-07-15

Family

ID=22883721

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95917181T ATE202633T1 (de) 1994-04-28 1995-04-28 Kalibrator für prothrombin-zeit-assays

Country Status (9)

Country Link
US (1) US5866425A (de)
EP (1) EP0706658B1 (de)
JP (1) JPH08512139A (de)
AT (1) ATE202633T1 (de)
AU (1) AU696924B2 (de)
CA (1) CA2165412A1 (de)
DE (1) DE69521470T2 (de)
ES (1) ES2160708T3 (de)
WO (1) WO1995030154A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5708591A (en) 1995-02-14 1998-01-13 Akzo Nobel N.V. Method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions
US6321164B1 (en) 1995-06-07 2001-11-20 Akzo Nobel N.V. Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
US6898532B1 (en) 1995-06-07 2005-05-24 Biomerieux, Inc. Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
US6429017B1 (en) 1999-02-04 2002-08-06 Biomerieux Method for predicting the presence of haemostatic dysfunction in a patient sample
AT403289B (de) * 1996-01-30 1997-12-29 Immuno Ag Verfahren zur herstellung eines standardisierten plasmapools für diagnostische zwecke
US6502040B2 (en) 1997-12-31 2002-12-31 Biomerieux, Inc. Method for presenting thrombosis and hemostasis assay data
WO2000046603A1 (en) 1999-02-04 2000-08-10 Akzo Nobel N.V. A method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
US7179612B2 (en) 2000-06-09 2007-02-20 Biomerieux, Inc. Method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality
DE10222234A1 (de) * 2002-05-16 2003-11-27 Roche Diagnostics Gmbh Kontroll- und Kalibrationsmaterial für Blutgerinnungstests
US7148067B2 (en) * 2004-08-31 2006-12-12 The Board Of Trustees Of The University Of Illinois Thromboplastin reagents
CN101151533A (zh) * 2005-02-16 2008-03-26 伊利诺斯大学理事会 基于金属螯合脂质的促凝血剂
DE602006021290D1 (de) * 2005-03-04 2011-05-26 Univ Illinois Modulator von coagulationskaskaden und fibrinolytischen kaskaden
DE102005028018A1 (de) * 2005-06-16 2006-12-21 Dade Behring Marburg Gmbh Verfahren zur Standardisierung von Gerinnungstesten
EP2040073A1 (de) 2007-09-20 2009-03-25 Iline Microsystems, S.L. Mikrofluidische Vorrichtung und Verfahren zur Flüssigkeitsgerinnungs-Zeitbestimmung
US8821861B2 (en) * 2007-10-05 2014-09-02 The Board Of Trustees Of The University Of Illinois Fibrin sealant
WO2009061697A1 (en) 2007-11-09 2009-05-14 The Board Of Trustees Of The University Of Illinois Anticoagulant antagonist and hemophilia procoagulant
EP2348319A1 (de) * 2010-01-21 2011-07-27 DIAGNOSTICA STAGO (Société par Actions Simplifiée) Verfahren zur Einstellung der Koagulationszeit bei einem Kalibrator oder bei Steuerungsplasmen
CN104181313B (zh) * 2014-09-04 2015-11-18 中国医学科学院输血研究所 凝血因子ⅸ质控品制备方法
EP3694322B1 (de) 2017-10-09 2024-07-03 Terumo BCT Biotechnologies, LLC Lyophilisierungsbehälter und verfahren zu seiner verwendung
CN108169467B (zh) * 2017-11-27 2019-09-20 中国科学院苏州生物医学工程技术研究所 一种血栓弹力图仪质控品及其制备方法和应用
US11604026B2 (en) 2019-03-14 2023-03-14 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4461833A (en) * 1982-06-23 1984-07-24 University Patents, Inc. Chromatographically purifying proteolytic procoagulant enzyme from animal tissue extract
DE3413311A1 (de) * 1984-04-09 1985-10-17 Behringwerke Ag, 3550 Marburg Reagenz zur bestimmung der thromboplastinzeit
DE3516579A1 (de) * 1984-11-19 1986-05-22 Boehringer Mannheim Gmbh, 6800 Mannheim Gerinnungstest auf teststreifen
US4721572A (en) * 1985-07-12 1988-01-26 Miles Laboratories, Inc. Purfication of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices
IE81149B1 (en) * 1987-02-12 2000-05-03 Genentech Inc Methods and deoxyribonucleic acid for the preparation of tissue factor protein
US5110730A (en) * 1987-03-31 1992-05-05 The Scripps Research Institute Human tissue factor related DNA segments
US4865984A (en) * 1988-02-08 1989-09-12 Mount Sinai School Of Medicine Of The City University Of New York Dynamic continuous flow enzyme reactor
WO1990005740A1 (en) * 1988-11-23 1990-05-31 Baxter International Inc. Improved extraction methods for preparing thromboplastin reagents
DE59109269D1 (de) * 1990-06-28 2005-12-15 Hoechst Ag Fusionsproteine mit Immunglobulinanteilen, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
US5866425A (en) 1999-02-02
WO1995030154A1 (en) 1995-11-09
CA2165412A1 (en) 1995-10-29
AU696924B2 (en) 1998-09-24
DE69521470D1 (en) 2001-08-02
ES2160708T3 (es) 2001-11-16
EP0706658A1 (de) 1996-04-17
JPH08512139A (ja) 1996-12-17
EP0706658B1 (de) 2001-06-27
DE69521470T2 (de) 2002-05-16
AU2397995A (en) 1995-11-29

Similar Documents

Publication Publication Date Title
ATE202633T1 (de) Kalibrator für prothrombin-zeit-assays
Kalafatis et al. Role of the membrane in the inactivation of factor Va by activated protein C.
Ryu et al. Porcine kallikrein‐4 activation, glycosylation, activity, and expression in prokaryotic and eukaryotic hosts
DE69832628D1 (de) Rekombinant-kaninchengewebefaktor basiertes prothrombinzeitreagenz
ES8605644A1 (es) Procedimiento para la preparacion de un suero de control o calibrado
SE8902532D0 (sv) Bestaemning av plasmaproteiner
DE69739996D1 (de) Methoden und Zusammensetzungen zur Herstellung von Polypeptiden
DE69535147D1 (de) Überexpression von säugetier- und virusproteinen
DE3886060D1 (de) Vorläuferprotein des APC-Polypeptids, dafür codierende DNA und diagnostische Verwendung der DNA und des Proteins.
CY1105446T1 (el) Διαγνωση και θepαπεια διαταραχων που συνδεονται με aur1 και aur2
FI864654A0 (fi) Menetelmä modifioidun ihmisen t-PA-proteiinin valmistamiseksi
ATE129155T1 (de) Verwendung von phosphatidylglycerol(dic 18:10) zur behandlung obstruktiver atemwegserkrankungen.
ATE196804T1 (de) Test für thrombosegefahr
Bader et al. Multicentric evaluation of a new PT reagent based on recombinant human tissue factor and synthetic phospholipids
DE69535814D1 (de) Kollagenherstellung in der milch von transgenen säugetieren
DE69513027D1 (de) Verfahren zur bestimmung des präthrombotischen status
DE69636922D1 (de) Verbesserte neurospora-wirtszellen zur herstellung rekombinanter proteine und methoden zu deren herstellung
Petrovan et al. Autocatalytic peptide bond cleavages in prothrombin and meizothrombin
Ireland et al. Apparent heterozygous Type II protein C deficiency caused by the factor V 506 Arg to Gin mutation
US6051434A (en) Activated protein C resistance test
DK0667872T3 (da) Mutantinterleukin 6 med forbedret biologisk aktivitet i forhold til vildtype-interleukin 6
Safa et al. Factor VIIa/tissue factor generates a form of factor V with unchanged specific activity, resistance to activation by thrombin, and increased sensitivity to activated protein C
AU3772595A (en) Calibrator for use in test methods for detecting a defective coagulation factor V
Kera et al. Isoelectric focusing pattern of human antithrombin III (AT‐III): Effects of heparin or thrombin on a microheterogeneous form of AT‐III
Berlet et al. Sequential limited proteolysis of myelin basic protein by neutral protease activities of bovine brain

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee